SelenBio, Inc.

The SelenBio team has developed a new safe, effective, non-toxic, cost-effective selenium-based antibacterial technology that kills even the most challenging bacteria. Bacteria and antimicrobial resistance (AMR) have emerged as one of the principal public health problems of the 21st century that threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi no longer susceptible to the common medicines used to treat them. SELDOX antimicrobial technology from SelenBio can become the new industry standard in preventing damaging bacteria that causes illness, infections and ever-increasing healthcare costs.

DenteShield™ dental products launched January 2018
European patents validated in 11 countries April 2018
Discussion started on integration of SELDOX® into silicone for use in urinary catheters and other medical devices June 2018
Joint development of wound care bandage began July 2018
R&D on incorporating SELDOX® into glaucoma tube October 2018
Integration and successful testing with paint application
Sublicense agreement signed for textile (cotton) application June 2019
GingiShield™ antibacterial dental sealant launched July 2019

Use Value % of Proceeds 

Working Capital

 

$0

 

0.0%

 

Intermediary fees

 

$52,430

 

4.9%

 

Kenny Gallagher
CEO
An instigator of innovation with unwavering determination to bring products to market, Kenny contributes selfless and ethical leadership, influences change, builds great talent, plans diligently, can monetize opportunities, and will execute relentlessly.

Karl Doenges
JD, President
Karl has extensive experience in starting, leading and managing companies in the healthcare, industrial and green-energy industries. Previously, Karl was an advisor for fuel, energy, technology and water to Cranberry Capital, Vice President of Marketing and Government Affairs for Gradiant Corporation, Chief Marketing Officer and Senior Vice President for Government Affairs and Business Development for Sweetwater Energy, President at Clean Fuel Distribution and Director of Global Marketing at Wagner and Brown, Ltd. In all of these positions, Karl managed the international aspect of business development and Government Affairs.

Matt Belsole
Director of Business Development
A proven sales leader with fifteen years’ experience in sales and management within the healthcare and medical device industries. Extensive knowledge of sales and marketing processes, strategies, and best practices across multiple channels and customer segments including B2B, B2C, Channel/Distributor Partners, and Healthcare.

Ted Reid
PhD, Chief Science Officer


Rob Hanes
PhD


Phat Tran
PhD


Bennett Amaechi
B.D.S., M.Sc., Ph.D., FADI